Polycythemia vera is a chronic myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the ...
The evolving treatment landscape in polycythemia vera (PV) is shifting from a focus on hematocrit control to a more ...
In this study we describe the clinical and morphologic features of patients with polycythemia vera who developed persistent and significant neutrophilic leukocytosis for the first time at or around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results